ALGOTHERAPEUTIX Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia
AGS THERAPEUTICS Named among Business Worldwide Magazines 20 Most Innovative Companies to Watch in 2023
Biophytis annonce les prochaines étapes règlementaires en Europe et aux Etats-Unis pour son projet COVA
